What if your doctors knew you were genetically predisposed to a certain health condition and could treat you better – and perhaps even preventing the disease? That's the goal of Cone Health's latest initiative with Helix, a California startup that has raised $403 million and worked with the NIH and CDC. Find out about their new joint venture to test 100,000 Triad patients here.
